Two-time Grand Slam champion Simona Halep will be ineligible to play professional tennis until October 2026 after the International Tennis Integrity Agency (ITIA) found that the Romanian violated the Tennis Anti-Doping Programme (TADP) at the ’22 U.S. Open.
Halep was discovered to have roxadustat in her system at the Grand Slam tournament last year, which prompted a suspension by the ITIA. The investigation also found that there were “irregularities in Halep’s Athlete Biological Passport (ABP).”
Roxadustat is a drug approved for medical use in the European Union to treat the symptoms of anemia caused by chronic kidney failure, according to the Associated Press.
